Search
Uridine-5'-diphosphate-2-deoxy-2-fluorogalactose
go.drugbank.com/drugs/DB02976ExperimentalSynonyms: Uridine-5'-diphosphate-2-deoxy-2-fluorogalactose2-deazo-6-thiophosphate guanosine-5'-monophosphate
go.drugbank.com/drugs/DB03146ExperimentalSynonyms: 2-deazo-6-thiophosphate guanosine-5'-monophosphateP-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid
go.drugbank.com/drugs/DB03752ExperimentalSynonyms: P-(2'-Iodo-5'-Thenoyl)Hydrotropic AcidCategories: Heterocyclic Compounds, 1-RingN-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE
go.drugbank.com/drugs/DB04762ExperimentalSynonyms: N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATECyclohexyl-pentyl-maltoside
go.drugbank.com/drugs/DB04664ExperimentalSynonyms: 5-cyclohexyl-1-pentyl-beta-D-maltoside, CYMAL(R)-5Dihydroergotamine
go.drugbank.com/drugs/DB00320ApprovedInvestigationalformulated at 75% of the strength of the existing intranasal product. … [A239569] The recently approved Precision Olfactory Delivery technology developed by Impel Neuropharma technology has correlated with an increase of 3-fold in Cmax and 4-fold in AUC despite the solution
Categories: Adrenergic alpha-1 Receptor Antagonists, Serotonin 5-HT1 Receptor AgonistsSynonyms: 5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trioneCladribine
go.drugbank.com/drugs/DB00242ApprovedInvestigationalCladribine is a purine analogue or a chlorinated derivative of adenine [A263733] that causes apoptosis of B and T lymphocytes. … [A350] Cladribine was first approved in the United States in 1993 [A263713] initially as a treatment for a number of hematological malignancies; currently, it is approved for the treatment of hairy cell
Categories: 2-Chloroadenosine, P-glycoprotein substratesSynonyms: (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol, 2-chloro-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purineMeropenem
go.drugbank.com/drugs/DB00760ApprovedInvestigationalMeropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. … In August 2017, a combination antibacterial therapy under the market name vabomere was approved for treatment of adult patients with complicated urinary tract infections (cUTI).
Categories: Heterocyclic Compounds, 2-RingSynonyms: (4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acidCephalexin
go.drugbank.com/drugs/DB00567ApprovedInvestigationalVet approved[A179071,A179074] This antibiotic contains a beta lactam and a dihydrothiazide. … [A179071] Cephalexin is used to treat a number of susceptible bacterial infections through inhibition of cell wall synthesis.[A179083,L6547] Cephalexin was approved by the FDA on 4 January 1971.
Synonyms: (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acidInternational brands: L-KeflexLevothyroxine
go.drugbank.com/drugs/DB00451ApprovedInvestigationaldeiodination (by type I or type II 5′-deiodinases)[A179941] into its active metabolite T<sub>3</sub>. … potency of ~1:4 (T4:T3).
Mixtures: BITIRON 50 MCG/12.5 MCG TABLET, 100 ADET, SYNTHROID® 112 MCG TABLETASCategories: P-glycoprotein inducers, Cytochrome P-450 CYP2C8 Inhibitors